NUDT15: A bench to bedside success story
Author:
- 1 June 2021
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 92, 1-8
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinicInternational Journal Of Clinical Practice, 2012
- Thiopurines, DNA damage, DNA repair and therapy-related cancerBritish Medical Bulletin, 2006
- Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurineGut, 2005
- Safe treatment of thiopurine S-methyltransferase deficient Crohn’s disease patients with azathioprineGut, 2003
- The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprineAlimentary Pharmacology & Therapeutics, 2001
- Human thiopurine methyltransferase activity varies with red blood cell ageBritish Journal of Clinical Pharmacology, 2001
- 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.Gut, 1996
- Individualizing Therapy with 6-Mercaptopurine and 6-Thioguanine Related to the Thiopurine Methyltransferase Genetic PolymorphismTherapeutic Drug Monitoring, 1996
- Human liver thiopurine methyltransferase pharmacogeneticsPharmacogenetics, 1992
- The Purine Path to ChemotherapyScience, 1989